Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China flag China · Delayed Price · Currency is CNY
46.10
-2.53 (-5.20%)
Feb 5, 2026, 3:13 PM CST

SHE:300255 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
247.91236.44230.92797.8543.21481.02
Cash & Short-Term Investments
247.91236.44230.92797.8543.21481.02
Cash Growth
-21.10%2.39%-71.06%46.87%12.93%-14.61%
Accounts Receivable
311.9265.74238.08452.99317.09427.22
Other Receivables
23.0142.5580.4343.0339.2443.75
Receivables
334.91308.29318.52496.02356.33470.97
Inventory
1,3421,3861,6442,4312,2851,887
Prepaid Expenses
---0.020.290.79
Other Current Assets
152.6671.9382.14172.24223.68159.64
Total Current Assets
2,0772,0022,2763,8983,4082,999
Property, Plant & Equipment
1,7631,7131,5911,4831,1931,064
Long-Term Investments
-7.5-1.465.818.18
Goodwill
---1.783.563.56
Other Intangible Assets
304.28308.13320.55263.82274.06251.6
Long-Term Deferred Tax Assets
18.2421.8920.9711.781419.88
Long-Term Deferred Charges
463.96432.58361.03286.26219.84150.17
Other Long-Term Assets
30.4636.8226.6589.8271.5665.61
Total Assets
4,6584,5234,5966,0365,1904,573
Accounts Payable
471.37307.47263.38249.81106.4982.35
Accrued Expenses
25.9128.1737.4654.2536.5767.48
Short-Term Debt
1,313887.55967.221,0101,2721,044
Current Portion of Long-Term Debt
537.96873.18586.14351.6134.226.01
Current Portion of Leases
-56.880.39---
Current Income Taxes Payable
3.532.361.143.4523.6234.38
Current Unearned Revenue
7.2214.5320.847.4565.8660.97
Other Current Liabilities
25.0232.6544.471.6595.31117.04
Total Current Liabilities
2,3842,2031,9211,7881,7341,412
Long-Term Debt
655.86659.47811.761,129332.47281.41
Long-Term Leases
80.2164.441.26---
Long-Term Unearned Revenue
58.2960.0162.4864.851.0225.37
Long-Term Deferred Tax Liabilities
0.270.310.350.190.20.48
Total Liabilities
3,1792,9872,7972,9822,1181,719
Common Stock
919.06919.06919.06934.97934.97934.97
Additional Paid-In Capital
422.74422.74422.74526.84526.84526.84
Retained Earnings
175.7220.52469.991,7941,8001,567
Treasury Stock
----120.01-120.01-120.01
Comprehensive Income & Other
-0.31-0.05-0.13-77.86-73.5-61.13
Total Common Equity
1,5171,5621,8123,0583,0692,848
Minority Interest
-38.69-26.52-11.97-4.023.345.65
Shareholders' Equity
1,4791,5361,8003,0543,0722,853
Total Liabilities & Equity
4,6584,5234,5966,0365,1904,573
Total Debt
2,5872,5422,3672,4901,7391,331
Net Cash (Debt)
-2,340-2,305-2,136-1,692-1,195-850.24
Net Cash Per Share
-2.23-2.49-2.32-1.93-1.28-0.91
Filing Date Shares Outstanding
919.06919.06919.06919.06919.06919.06
Total Common Shares Outstanding
919.06919.06919.06919.06919.06919.06
Working Capital
-307.14-200.38354.942,1101,6741,587
Book Value Per Share
1.651.701.973.333.343.10
Tangible Book Value
1,2131,2541,4912,7922,7912,592
Tangible Book Value Per Share
1.321.361.623.043.042.82
Buildings
-932.88915.66808.9701.24691.37
Machinery
-538.71545.8389.26339.53335.51
Construction In Progress
-708.97547.74642.27462.72311.26
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.